Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
HRZN 
Horizon Technology Finance (HRZN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: HRZN (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $6.75
1 Year Target Price $6.75
| 0 | Strong Buy |
| 1 | Buy |
| 6 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -32.37% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 283.78M USD | Price to earnings Ratio - | 1Y Target Price 6.75 |
Price to earnings Ratio - | 1Y Target Price 6.75 | ||
Volume (30-day avg) 8 | Beta 0.98 | 52 Weeks Range 6.54 - 9.35 | Updated Date 09/16/2025 |
52 Weeks Range 6.54 - 9.35 | Updated Date 09/16/2025 | ||
Dividends yield (FY) 19.33% | Basic EPS (TTM) -1.19 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -48.76% | Operating Margin (TTM) 81.66% |
Management Effectiveness
Return on Assets (TTM) 6.52% | Return on Equity (TTM) -15.47% |
Valuation
Trailing PE - | Forward PE 6.17 | Enterprise Value 684253952 | Price to Sales(TTM) 2.92 |
Enterprise Value 684253952 | Price to Sales(TTM) 2.92 | ||
Enterprise Value to Revenue 11.11 | Enterprise Value to EBITDA 13.46 | Shares Outstanding 42545700 | Shares Floating - |
Shares Outstanding 42545700 | Shares Floating - | ||
Percent Insiders 1.26 | Percent Institutions 6.59 |
Upturn AI SWOT
Horizon Technology Finance
Company Overview
History and Background
Horizon Technology Finance Corporation (HRZN) was founded in 2004 and completed its IPO in 2010. It's a specialty finance company that provides capital to venture capital and private equity-backed companies in the technology, life science, healthcare information and services, and cleantech industries.
Core Business Areas
- Venture Debt: Provides secured loans to venture capital-backed companies. These loans are often used for working capital, acquisitions, and expansion.
- Mezzanine Debt: Offers subordinated debt financing, which is typically riskier than senior debt and carries higher interest rates, along with warrants.
- Equity Investments: Makes select equity investments, often in conjunction with debt financing.
Leadership and Structure
Robert Pomeroy is the CEO and Chairman. The company operates as a business development company (BDC) and is externally managed by Horizon Technology Advisors LLC.
Top Products and Market Share
Key Offerings
- Senior Secured Loans: Provides senior secured loans to venture-backed companies. Interest income from these loans forms the bulk of Horizon's revenue. Market share data is not readily available, but HRZN is a notable player in the venture debt market. Competitors: Ares Capital, Trinity Capital, SLR Investment Corp.
- Warrants: Often receives warrants in conjunction with loans, offering potential equity upside. The value of these warrants is volatile. Market share information is not publicly available. Competitors: Hercules Capital.
Market Dynamics
Industry Overview
The venture debt market provides financing to high-growth, often unprofitable, companies backed by venture capital. It's a cyclical market influenced by venture capital activity and interest rates. Recent high interest rates have increased funding costs for venture debt lenders, while reduced valuations for venture-backed companies impacts asset quality.
Positioning
Horizon is a leading provider of venture debt to technology and life science companies. Its competitive advantage lies in its expertise in these sectors and its established relationships with venture capital firms.
Total Addressable Market (TAM)
The TAM for venture debt is estimated to be in the tens of billions of dollars annually. Horizon's position allows them to capture a portion of this market through their established lending programs.
Upturn SWOT Analysis
Strengths
- Experienced management team
- Strong relationships with venture capital firms
- Focus on high-growth sectors
- Track record of generating attractive yields
Weaknesses
- High dependence on external management
- Concentrated portfolio in technology and life sciences
- Sensitivity to interest rate changes
- Reliance on continued venture capital funding
Opportunities
- Expansion into new sectors
- Increased demand for venture debt due to tight credit markets
- Growth in the technology and life science industries
- Strategic partnerships
Threats
- Economic downturn
- Increased competition in the venture debt market
- Regulatory changes
- Rising interest rates
- Deterioration in the credit quality of portfolio companies
Competitors and Market Share
Key Competitors
- ARCC
- TCPC
- SLRC
- HTGC
Competitive Landscape
Horizon faces competition from other BDCs and traditional lenders. Its advantages include its focus on technology and life sciences and its established relationships with venture capital firms. A main disadvantage is its relatively small size compared to industry giants like Ares Capital.
Growth Trajectory and Initiatives
Historical Growth: Growth has been driven by increased loan originations and expansion into new sectors. However, growth can be volatile due to market conditions and the cyclical nature of the venture debt market.
Future Projections: Future growth depends on Horizon's ability to continue originating high-quality loans and managing its portfolio effectively. Analyst estimates vary depending on market conditions and company-specific factors.
Recent Initiatives: Horizon is focused on expanding its relationships with venture capital firms and diversifying its portfolio across different sectors.
Summary
Horizon Technology Finance is a BDC specializing in venture debt for technology and life science companies, presenting both high-yield opportunities and considerable risks tied to the venture capital ecosystem. Its strengths lie in its experienced management and sector focus, while weaknesses include external management and portfolio concentration. The company's future hinges on its ability to manage credit risk, navigate interest rate fluctuations, and capitalize on growth in its target sectors, making it a moderate-risk investment.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC filings
- Company website
- Earnings call transcripts
- Analyst reports
- Latest Quarterly Report (Q1 2024)
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor. Market share data is estimated based on available information and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Horizon Technology Finance
Exchange NASDAQ | Headquaters Farmington, CT, United States | ||
IPO Launch date 2010-10-29 | CEO & Director Mr. Michael Phillip Balkin | ||
Sector Financial Services | Industry Asset Management | Full time employees - | |
Full time employees - | |||
Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, cleantech and sustainability industries. It seeks to invest in companies in the United States.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.